Earnings before Non-Cash Charges Earnings before non-cash charges is defined as net income, adjusted for the following non-cash charges, as applicable: (i) interest; (ii) income taxes; (iii) license fees; (iv) depreciation and amortization; (v) impairment charges; and (vi) share-based compensation (stock option and share tracking award expense).
The following table provides a reconciliation of net income to earnings before non-cash charges for each of the quarters ended September 30, 2010 and 2009 (in thousands, except per share data):Three Months Ended
September 30,20102009Net income, as reported$
11,937Adjust for non-cash charges:Interest expense4,8093,331Income tax expense (benefit)17,998(2,891)License fees --Depreciation and amortization5,0282,505Impairment charges-399Share-based compensation31,50025,293Earnings before non-cash charges$
40,574Earnings before non-cash charges per share(1):Basic$
0.70(1) Calculated by dividing earnings before non-cash charges by the basic and diluted weighted average number of common shares outstanding, as reported below in our Consolidated Statements of Operations.Conference CallWe will host a half-hour teleconference on Thursday, October 28, 2010 at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using conference code: 14787030.
This teleconference is also be
|SOURCE United Therapeutics Corporation|
Copyright©2010 PR Newswire.
All rights reserved